enGene Therapeutics (ENGN) Non-Current Assets (2022 - 2026)
enGene Therapeutics (ENGN) recorded Non-Current Assets of $10.42 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), down 69.6% from $34.24 million a year earlier and down 72.2% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics reported Non-Current Assets of $20.08 million, down 68.5% from FY2024.
- Annual Non-Current Assets has a three-year compound annual growth rate of 147.4% (FY2022 to FY2025).
- Across earlier fiscal years, Non-Current Assets came in at $63.81 million in FY2024, $1.52 million in FY2023 (+14.6%) and $1.33 million in FY2022.
- The fiscal Q3 2026 figure is the lowest quarterly Non-Current Assets since fiscal Q3 2024.
- On a year-over-year basis, Non-Current Assets has declined for four consecutive quarters, with growth averaging 239.9% over the last six quarters.
- Per Business Quant, the preceding three fiscal quarters came in at $37.52 million (Q2 2026), $47.9 million (Q1 2026) and $20.08 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | enGene Therapeutics | 134.03 Mn | 134.03 Mn | - | 10.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 10.42 Mn |
| Apr 30, 2026 | 37.52 Mn |
| Jan 31, 2026 | 47.90 Mn |
| Oct 31, 2025 | 20.08 Mn |
| Jul 31, 2025 | 34.24 Mn |
| Apr 30, 2025 | 38.68 Mn |
| Jan 31, 2025 | 63.61 Mn |
| Oct 31, 2024 | 63.81 Mn |
| Jul 31, 2024 | 4.19 Mn |
| Apr 30, 2024 | 3.92 Mn |
| Jan 31, 2024 | 3.84 Mn |
| Oct 31, 2023 | 1.52 Mn |
| Oct 31, 2022 | 1.33 Mn |
API Access
enGene Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();